Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Heart Rhythm ; 8(2): 263-70, 2011 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-20950708

RESUMO

BACKGROUND: QT interval correction formulas are based on instantaneous heart rate (HR), but QT interval adaptation to sudden HR change occurs gradually. In humans, the QT interval has been reported to reach a new steady-state value in about 2 minutes. OBJECTIVE: This study sought to assess ß-adrenergic stimulation effects on QT interval response to HR change. METHODS: Ten subjects (42.1 ± 15.3 years, 3 men) undergoing radiofrequency ablation of supraventricular tachycardia were studied. Atrial pacing for 5 minutes at an HR ranging from 60 to 140 beats/min was performed before and during dobutamine infusion (10 µg/kg/min). The QT response to sudden HR change was evaluated. RESULTS: The QT response to sudden HR change consists of an immediate response (IR), followed by a gradual monoexponential course to the new steady-state value. Linear function results in inferior fit of QT adaptation course (P < .05 compared with exponential). The time constant of the exponential is approximately 1 minute (50.9 ± 11.4 seconds). The IR magnitude is approximately 3% of the RR interval change (2.97% ± 2.01%). Dobutamine shortens steady-state QT at given HR (from 301.8 ± 11.2 ms to 290.6 ± 13.2 ms at 120 beats/min; P < .001) and increases IR magnitude (to 13.28% ± 8.99% of RR change; P < .01). During sinus rhythm, QT variability and QT variability index were significantly increased by dobutamine. CONCLUSION: QT adaptation has 2 distinct phases, which might have different mechanisms. The effect of ß-adrenergic stimulation on IR may increase QT variability by increasing the immediate response to HR variability. These results may be important in the assessment of drug effects on repolarization and for understanding of QT variability.


Assuntos
Antagonistas de Receptores Adrenérgicos beta 1/administração & dosagem , Dobutamina/administração & dosagem , Eletrocardiografia , Síndrome do QT Longo/tratamento farmacológico , Taquicardia Supraventricular/tratamento farmacológico , Adaptação Fisiológica/efeitos dos fármacos , Adulto , Estimulação Cardíaca Artificial/métodos , Ablação por Cateter/métodos , Esquema de Medicação , Feminino , Seguimentos , Frequência Cardíaca/efeitos dos fármacos , Humanos , Infusões Intravenosas , Modelos Lineares , Síndrome do QT Longo/diagnóstico , Masculino , Pessoa de Meia-Idade , Estudos de Amostragem , Índice de Gravidade de Doença , Taquicardia Supraventricular/diagnóstico , Taquicardia Supraventricular/cirurgia , Resultado do Tratamento
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...